Organic Chemistry Methods TRIZ Cases

A fused polycyclic compound in an emission layer reduces intermolecular interactions to enhance device performance.

A deuterated carbazole-triazine compound enhances electron injection and transport in organic optoelectronic devices.

A pyrene derivative host compound optimizes energy band gaps to enhance luminescent properties in organic light-emitting devices.

A one-pot reaction system combines hexafluoroacetone monohydrate with metal fluoride to produce 1,3-dioxolane compounds efficiently.

A fused polycyclic compound host material reduces driving voltage and extends lifespan by preventing intermolecular interactions.

Direct crystallization eliminates chromatographic purification, reducing hazardous solvent use and production costs.

Distinct fluorene-amine compounds in segmented hole transport layers resolve the trade-off between low driving voltage and structural complexity.

Specific pyrimidine derivatives target the alpha 6 subunit to inhibit dopamine release, resolving low specificity in current psychiatric treatments.

Adamantane spiro-bonded fluorene structures boost service life beyond 10,000 hours while maintaining thermal stability and reducing working voltage.

Simultaneous recrystallization of two intermediates with an amine base reduces waste and yield loss while maintaining high purity.

Selective hydrogenation of 2,5-bis(aminomethyl)furan using a metal complex catalyst eliminates by-product formation and simplifies purification.

Segmented synthesis of histamine H3 receptor modulators resolves trade-offs between therapeutic efficacy and pharmaceutical properties.

Photochemical isomerization of HFO-1132 mixtures eliminates iodine corrosion and reduces separation waste.

Neutralizing agents react with corrosive acids to protect inexpensive distillation columns while maintaining acetaldehyde separation efficiency.

Converts fluorescein mesylate salt into quinoid form to resolve filtration issues and remove methane sulfonic acid residues.

Optimized reaction parameters using EDC hydrochloride and ethyl cyanohydroxyiminoacetate improve synthesis efficiency while maintaining high compound purity.

Diastereomeric salt formation with gulonic acid enriches spirocyclic TPH1 inhibitor isomers, resolving low enantiomeric excess in synthesis.

Integrating polymerization and pyrolysis into one reactor eliminates multi-step isolation, reducing capital costs while maintaining high acrylic acid purity.

Carbazole-bonded nitrogen compounds lower driving voltage and boost light efficiency by maintaining high triplet excitation energy levels to protect dopants.

Combining diazadibenzofuran electron hosts with biscarbazole hole hosts in organic electroluminescent devices.

Hexanohydroxamic acid derivatives inhibit histone deacetylase and HMG-CoA reductase to overcome drug resistance in hypoxic cancer cells.

Host material with wider band gap resolves Joule heating trade-off, improving color purity and device lifespan.

RORγt agonists increase IL-17A and GM-CSF levels, enhancing antitumor immunity while managing autoimmune risks through inverse modulation.

Crystalline form CS1 of vadadustat resolves poor preparation repeatability by delivering stable anhydrate structures with improved bioavailability.

Characterized crystal forms of crisaborole deliver improved stability and bioavailability without complex manufacturing processes.

A novel host compound enhances luminous efficiency and color purity in organic electronic elements.

Fragment coupling in solution phase synthesizes Foxy-5 to resolve scalability bottlenecks inherent in solid-phase peptide synthesis.

Crystalline forms E and D of Compound 1 inhibit pathological angiogenesis, resolving the trade-off between therapeutic efficacy and manufacturing complexity.

A mixed host system combines deuterated anthracene with a nitrogen-containing hole-blocking compound to boost device performance.

Asymmetrically substituted Pt complexes with doubly-substituted aryl groups achieve saturated red, green, and blue emissions for full-color displays.

Optimized lipophilicity and specific substituents enhance sensitivity and specificity for detecting P-glycoprotein expression in cancer tissues.

Crystal form X of lenvatinib mesylate resolves low bioavailability by improving solubility and stability via methanesulfonic acid crystallization.

Crystallizing thiamine hydrochloride from a controlled isopropanol-water mixture yields stable pharmaceutical-grade hemihydrate crystals.

A multi-step synthetic process for quinazoline compounds replaces hazardous reagents with safer alternatives to enable multikilogram production.

A charge generation layer with a crystalline compound reduces operating voltage and extends device lifetime by preventing dopant diffusion.

Purified sacubitril sodium converts to stable amorphous form using ketone-alcohol solvents, maintaining structure at 40°C and 75% humidity for six months.

Double-belt cooling solidifies L-menthol melt into stable alpha flakes, eliminating caking and enabling continuous production.

Transforming the amorphous solid into defined crystalline phases AB, M, and F resolves storage instability while enabling high-yield manufacturing.

Segmented synthesis yields stable crystal forms of HIV integrase inhibitors, resolving trade-offs between production efficiency and manufacturing precision.

Azeotropic distillation with toluene or cyclopentyl methyl ether concentrates the solution for direct crystallization of optically active 2-methylpiperazine.

Composite hole transport materials with tetraphenyl naphthalene derivatives lower driving voltage and extend device life by managing exciton energy diffusion.

Specific host material combinations reduce driving voltage and extend device lifespan by balancing charge transport with exciton management.

A 2-heteroaryl aminoquinazolinone derivative suppresses neural circuit hyperexcitation to treat neurological disorders.

Copper-mediated coupling of halogenated olefins replaces expensive palladium catalysts and high-temperature thermal cyclization for low-cost production.

Acetonitrile crystallization yields Lenvatinib mesylate Form M, resolving inconsistent bioavailability from variable existing polymorphs.

Crystalline Form A of amisulpride achieves high chiral purity through controlled solvent treatment, resolving reproducibility issues in enantiomer production.

Lowering the HOMO energy level of an organometallic compound stabilizes dipole moments to resolve trade-offs between color purity and luminescence efficiency.

Non-carboxylic acid solvents in apremilast synthesis reduce deacetyl impurities below one percent without extra purification.

A boron-based dopant paired with an anthracene host material in the light-emitting layer of an organic electroluminescent element.